Scientific advisors

Isarna Therapeutics is supported by an international team of scientists, researchers, and clinicians who are leading experts in the fields of TGF-β, translational medicine, ophthalmology and oncology.

Rosemary Akhurst, Ph.D.

Professor and Director of Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA

Alon Harris, Ph.D., FARVO

Professor of Ophthalmology, Director of Clinical Research, Professor of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, USA

Ugur Sahin, M.D.

Professor of Experimental Oncology, Founder and Managing Director (Science and Research) of TRON GmbH, Mainz, Germany

David Spalton, M.D.

Professor of Ophthalmology, The London Clinic Eye Centre, London, United Kingdom

Walter Stark, M.D.

Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of the Wilmer Eye Institute at the Johns Hopkins Medical Institutions, Johns Hopkins University, Baltimore, USA

Josep Tabernero, M.D.

Professor and Director of Vall d'Hebron Institute of Oncology, Head Medical Oncology Department, Director Clinical Research, Barcelona, Spain

Rohit Varma, M.D.

Professor and Chair of the Department of Ophthalmology at the University of Southern California and Director USC Eye Institute, Keck School of Medicine of USC, Los Angeles, USA

Michael Weller, M.D.

Professor of Neurology, Chairman of the Department of Neurology, University Hospital Zurich, Switzerland

Michael Wormstone, Ph.D.

Faculty Member and Senior Lecturer at the School of Biological Sciences, University of East Anglia, Norwich, United Kingdom